Pirollo K - Search Results

1

Hepatitis C virus clearance correlates with HLA-DR expression on proliferating CD8+ T cells in immune-primed chimpanzees.

Zubkova I, Duan H, Wells F, Mostowski H, Chang E, Pirollo K, Krawczynski K, Lanford R, Major M. Zubkova I, et al. Among authors: pirollo k. Hepatology. 2014 Mar;59(3):803-13. doi: 10.1002/hep.26747. Epub 2014 Jan 28. Hepatology. 2014. PMID: 24123114 Free PMC article.

2

The status of the p53 gene in human papilloma virus positive or negative cervical carcinoma cell lines.

Srivastava S, Tong YA, Devadas K, Zou ZQ, Chen Y, Pirollo KF, Chang EH. Srivastava S, et al. Among authors: pirollo kf. Carcinogenesis. 1992 Jul;13(7):1273-5. doi: 10.1093/carcin/13.7.1273. Carcinogenesis. 1992. PMID: 1322252

3

raf involvement in the simultaneous genetic transfer of the radioresistant and transforming phenotypes.

Pirollo KF, Garner R, Yuan SY, Li L, Blattner WA, Chang EH. Pirollo KF, et al. Int J Radiat Biol. 1989 May;55(5):783-96. doi: 10.1080/09553008914550831. Int J Radiat Biol. 1989. PMID: 2565939

4

Tumor-targeted p53-gene therapy enhances the efficacy of conventional chemo/radiotherapy.

Xu L, Pirollo KF, Chang EH. Xu L, et al. Among authors: pirollo kf. J Control Release. 2001 Jul 6;74(1-3):115-28. doi: 10.1016/s0168-3659(01)00324-8. J Control Release. 2001. PMID: 11489488 Review.

5

Targeted delivery of small interfering RNA: approaching effective cancer therapies.

Pirollo KF, Chang EH. Pirollo KF, et al. Cancer Res. 2008 Mar 1;68(5):1247-50. doi: 10.1158/0008-5472.CAN-07-5810. Cancer Res. 2008. PMID: 18316585 Review.

6

Does a targeting ligand influence nanoparticle tumor localization or uptake?

Pirollo KF, Chang EH. Pirollo KF, et al. Trends Biotechnol. 2008 Oct;26(10):552-8. doi: 10.1016/j.tibtech.2008.06.007. Epub 2008 Aug 21. Trends Biotechnol. 2008. PMID: 18722682

7

T-cell vaccines that elicit effective immune responses against HCV in chimpanzees may create greater immune pressure for viral mutation.

Zubkova I, Choi YH, Chang E, Pirollo K, Uren T, Watanabe H, Wells F, Kachko A, Krawczynski K, Major ME. Zubkova I, et al. Among authors: pirollo k. Vaccine. 2009 Apr 28;27(19):2594-602. doi: 10.1016/j.vaccine.2009.02.045. Epub 2009 Feb 24. Vaccine. 2009. PMID: 19428866

8

A tumor-targeting p53 nanodelivery system limits chemoresistance to temozolomide prolonging survival in a mouse model of glioblastoma multiforme.

Kim SS, Rait A, Kim E, Pirollo KF, Chang EH. Kim SS, et al. Nanomedicine. 2015 Feb;11(2):301-11. doi: 10.1016/j.nano.2014.09.005. Epub 2014 Sep 18. Nanomedicine. 2015. PMID: 25240597 Free PMC article.

9

Isolation and Culturing of Glioma Cancer Stem Cells.

Kim SS, Pirollo KF, Chang EH. Kim SS, et al. Curr Protoc Cell Biol. 2015 Jun 1;67:23.10.1-23.10.10. doi: 10.1002/0471143030.cb2310s67. Curr Protoc Cell Biol. 2015. PMID: 26061242 Free PMC article.

10

Effective treatment of glioblastoma requires crossing the blood-brain barrier and targeting tumors including cancer stem cells: The promise of nanomedicine.

Kim SS, Harford JB, Pirollo KF, Chang EH. Kim SS, et al. Biochem Biophys Res Commun. 2015 Dec 18;468(3):485-9. doi: 10.1016/j.bbrc.2015.06.137. Epub 2015 Jun 24. Biochem Biophys Res Commun. 2015. PMID: 26116770 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

66 results

Search Page

Filters